Company: CPMV
Filing Date: 2025-04-15
Form Type: 10-K
Source: 0001683168-25-002584
Chunk: 40

Company: Mosaic ImmunoEngineering Inc.
Filing Date: 2025-04-15
Form: 10-K
Item: Item 1
Chunk 40
---
, preferences as to dividends and liquidation, conversion and redemption rights, and sinking fund provisions. As we seek
capital for our business, such capital may be raised through the issuance of preferred stock.

 23 

Our executive officers, directors and principal
stockholders, if they choose to act together, will have the ability to control all matters submitted to stockholders for approval. 

Shareholders of Private Mosaic beneficially own shares
representing a majority of our capital stock outstanding as of December 31, 2024. As a result, if these stockholders were to choose to
act together, they would be able to control all matters submitted to our stockholders for approval, as well as our management and affairs.
For example, these persons, if they choose to act together, would control the election of directors and approval of any merger, consolidation
or sale of all or substantially all of our assets. This concentration of ownership control may:

    ·
    delay, defer or prevent a change in control;

    ·
    entrench our management and the board of directors; or

    ·
    impede a merger, consolidation, takeover or other business combination involving the Company that other stockholders may desire.

In addition, if we enter into a definitive agreement
with Oncotelic under the binding term sheet to acquire certain rights to their technology (see Note 13 to the accompanying consolidated
financial statements), we would issue Oncotelic 47,923,322 shares of common stock and Oncotelic would own a majority of shares of common
stock of the Company and would be able to control all matters at the Company.

Our amended and restated certificate of incorporation
and amended and restated bylaws provides that state or federal court located within the state of Delaware will be the sole and exclusive
forum for substantially all disputes between us and our stockholders, which could limit its stockholders’ ability to obtain a favorable
judicial forum for disputes with us or our directors, officers or other employees.

Section XIV of our amended and restated certificate
of incorporation provides that “Unless the Corporation consents in writing to the selection of an alternative forum, the Court of
Chancery of the State of Delaware shall, to the fullest extent permitted by applicable law, be the sole and exclusive forum for any stockholder
(including a beneficial owner) to bring (A) any derivative action or proceeding brought on behalf of the Corporation, (B) any action asserting
a claim of breach of a fiduci